Laser Treatment Offers New Hope for Glaucoma Management

A study reveals that laser treatment slows glaucoma progression better than traditional eye drops, sparking a change in disease management. Selective laser trabeculoplasty, shown effective in clinical trials, offers a safe alternative, with the American Academy of Ophthalmology endorsing its use.

Recent findings unveiled at a medical conference suggest a significant shift in glaucoma management, replacing standard eye drop therapy with a laser procedure. Researchers have confirmed that selective laser trabeculoplasty is not only as effective as the traditional method but also better at slowing disease progression.

An analysis six years after the trial involving 700 patients showed a 29% slower progression rate in those treated with the laser. These findings were presented at the American Academy of Ophthalmology meeting in Chicago, indicating that laser-treated patients were less likely to require glaucoma surgery.

The American Academy of Ophthalmology has recognized the laser procedure as a viable alternative or supplementary treatment to eye drops, noting its effectiveness in reducing vision loss. Given its promising results, experts believe this method could revolutionize the standard care for glaucoma, affecting millions globally.

(With inputs from agencies.)